J R de Leeuw1, A de Graeff, W J Ros, G H Blijham, G J Hordijk, J A Winnubst. 1. Research Group Psychology of Health and Illness, Department of Nursing Sciences, Faculty of Medicine, University Medical Center, PO Box 80036, 3508TA, Utrecht, The Netherlands.
Abstract
BACKGROUND: Head and neck cancer and its treatment can have important psychosocial implications. Many patients become depressed. The aim of this prospective study is to examine whether pretreatment variables can be used to predict depression up to 3 years after treatment. METHODS: Head and neck cancer patients (n = 197) treated with surgery and/or radiotherapy completed both before and after treatment a questionnaire including items on social support, coping, depressive symptoms, physical functioning, and physical symptoms. RESULTS: Eight pretreatment variables (tumor stage, sex, depressive symptoms, openness to discuss cancer in the family, available appraisal support, received emotional support, tumor-related symptoms, and size of the informal social network) were used to calculate a risk score to determine which patients were depressed at 6 months to 3 years after treatment (positive predicted value, 58%; negative predicted value, 83%). CONCLUSIONS: Eight pretreatment variables can be used to predict accurately those head and neck cancer patients who are likely to become depressed up to 3 years after treatment. Copyright 2001 John Wiley & Sons, Inc. Head Neck 23: 892-898, 2001.
BACKGROUND: Head and neck cancer and its treatment can have important psychosocial implications. Many patients become depressed. The aim of this prospective study is to examine whether pretreatment variables can be used to predict depression up to 3 years after treatment. METHODS: Head and neck cancerpatients (n = 197) treated with surgery and/or radiotherapy completed both before and after treatment a questionnaire including items on social support, coping, depressive symptoms, physical functioning, and physical symptoms. RESULTS: Eight pretreatment variables (tumor stage, sex, depressive symptoms, openness to discuss cancer in the family, available appraisal support, received emotional support, tumor-related symptoms, and size of the informal social network) were used to calculate a risk score to determine which patients were depressed at 6 months to 3 years after treatment (positive predicted value, 58%; negative predicted value, 83%). CONCLUSIONS: Eight pretreatment variables can be used to predict accurately those head and neck cancerpatients who are likely to become depressed up to 3 years after treatment. Copyright 2001 John Wiley & Sons, Inc. Head Neck 23: 892-898, 2001.
Authors: Namie Okino Sawada; Juliana Maria de Paula; Helena Megumi Sonobe; Marcia Maria Fontão Zago; Giselle Patricia Guerrero; Adriana Cristina Nicolussi Journal: Support Care Cancer Date: 2012-11 Impact factor: 3.603
Authors: Camilla Zimmermann; Debika Burman; Nadia Swami; Monika K Krzyzanowska; Natasha Leighl; Malcolm Moore; Gary Rodin; Ian Tannock Journal: Support Care Cancer Date: 2010-03-30 Impact factor: 3.603
Authors: Mary Ellen Haisfield-Wolfe; Deborah B McGuire; Karen Soeken; Jeanne Geiger-Brown; Bruce De Forge; Mohan Suntharalingam Journal: Support Care Cancer Date: 2011-10-04 Impact factor: 3.603
Authors: D R Sullivan; C W Forsberg; L Ganzini; D H Au; M K Gould; D Provenzale; K S Lyons; C G Slatore Journal: Lung Cancer Date: 2016-08-16 Impact factor: 5.705
Authors: Ingeborg C van der Meulen; Anne M May; Wynand J G Ros; Miriam Oosterom; Gert-Jan Hordijk; Ron Koole; J Rob J de Leeuw Journal: Oncologist Date: 2013-02-21
Authors: Aru Panwar; Katherine Rieke; William J Burke; Harlan Sayles; William M Lydiatt Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-11-01 Impact factor: 6.223
Authors: Douglas E Morse; Walter J Psoter; Linda S Baek; Ellen Eisenberg; Donald Cohen; Deborah Cleveland; Mirseyed Mohit-Tabatabai; Susan Reisine Journal: Head Neck Date: 2010-05 Impact factor: 3.147